Aura Biosciences (AURA) Change in Cash (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Change in Cash data on file, last reported at $25.3 million in Q1 2026.

• Quarterly Change in Cash rose 286.1% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.8 million (up 290.7% YoY) and the FY2025 annual result came in at $28.0 million, up 398.31% from the prior year.
• Change in Cash advanced to $25.3 million in Q1 2026, from $12.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $69.1 million in Q2 2025 to a low of -$83.1 million in Q1 2023.
• A 5-year average of -$3.7 million and a median of $6.3 million in 2024 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 1721.18% in 2025, down 1181.06% in 2025.
• Tracing AURA's Change in Cash over 5 years: stood at $60.3 million in 2022, then sank by 124.08% to -$14.5 million in 2023, then soared by 143.29% to $6.3 million in 2024, then jumped by 92.84% to $12.1 million in 2025, then surged by 108.75% to $25.3 million in 2026.
• The last three Change in Cash figures came in at $25.3 million (Q1 2026), $12.1 million (Q4 2025), and -$59.8 million (Q3 2025), per Business Quant data.